Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
14.46
+0.40 (2.84%)
May 29, 2026, 2:29 PM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $31.75 million as of May 29, 2026. Its market cap has increased by 458.84% in one year.
Market Cap
31.75M
Enterprise Value
28.24M
1-Year Change
458.84%
Ranking
Category
Stock Price
$14.46
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $31.75M, a decrease of -75.50%. That is a compound annual growth rate of -26.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 30.88M | -23.04% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 31.65M |
| Senti Biosciences Holdings | 31.46M |
| Tvardi Therapeutics | 30.96M |
| Polyrizon | 30.87M |
| Tevogen Bio Holdings | 30.11M |
| Lisata Therapeutics | 29.81M |
| GridAI Technologies | 29.39M |
| Neuphoria Therapeutics | 29.18M |